These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 30778879

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Alglucosidase alfa therapy for Pompe disease in pregnancy - Case report.
    Kłos J, Kwaśniak-Butowska M, Sławek J.
    J Neurol Sci; 2017 Apr 15; 375():167-169. PubMed ID: 28320122
    [No Abstract] [Full Text] [Related]

  • 24. The new era of Pompe disease: advances in the detection, understanding of the phenotypic spectrum, pathophysiology, and management.
    Kishnani PS, Beckemeyer AA, Mendelsohn NJ.
    Am J Med Genet C Semin Med Genet; 2012 Feb 15; 160C(1):1-7. PubMed ID: 22253049
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. New insights into therapeutic options for Pompe disease.
    Richard E, Douillard-Guilloux G, Caillaud C.
    IUBMB Life; 2011 Nov 15; 63(11):979-86. PubMed ID: 22002928
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. A new assay for fast, reliable CRIM status determination in infantile-onset Pompe disease.
    Wang Z, Okamoto P, Keutzer J.
    Mol Genet Metab; 2014 Feb 15; 111(2):92-100. PubMed ID: 24044919
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Infantile Pompe disease: clinical and genetic characteristics with an experience of enzyme replacement therapy.
    Cho A, Kim SJ, Lim BC, Hwang H, Park JD, Kim GB, Jin DK, Lee J, Ki CS, Kim KJ, Hwang YS, Chae JH.
    J Child Neurol; 2012 Mar 15; 27(3):319-24. PubMed ID: 21940687
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. New therapeutic approaches for Pompe disease: enzyme replacement therapy and beyond.
    Kishnani PS, Beckemeyer AA.
    Pediatr Endocrinol Rev; 2014 Sep 15; 12 Suppl 1():114-24. PubMed ID: 25345093
    [Abstract] [Full Text] [Related]

  • 38. 24-months results in two adults with Pompe disease on enzyme replacement therapy.
    Vielhaber S, Brejova A, Debska-Vielhaber G, Kaufmann J, Feistner H, Schoenfeld MA, Awiszus F.
    Clin Neurol Neurosurg; 2011 Jun 15; 113(5):350-7. PubMed ID: 21477922
    [Abstract] [Full Text] [Related]

  • 39. Pompe disease: a review of the current diagnosis and treatment recommendations in the era of enzyme replacement therapy.
    Katzin LW, Amato AA.
    J Clin Neuromuscul Dis; 2008 Jun 15; 9(4):421-31. PubMed ID: 18525427
    [Abstract] [Full Text] [Related]

  • 40. Immune modulation in Pompe disease treated with enzyme replacement therapy.
    Banugaria SG, Patel TT, Kishnani PS.
    Expert Rev Clin Immunol; 2012 Aug 15; 8(6):497-9. PubMed ID: 22992140
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.